Insulin Pump vs. Full Closed-Loop for Type 2 Diabetes
Part of Hormones & metabolism clinical trials.
This trial compares your current insulin pump therapy with a fully automated closed-loop system (artificial pancreas) that adjusts insulin using a smartphone algorithm. It aims to see which method works better for managing blood sugar levels in people with type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had type 2 diabetes for at least 1 year.
- You have been using an insulin pump for at least 6 months.
- You are comfortable managing your pump and glucose sensor on your own.
- Your HbA1c level (average blood sugar over 2-3 months) is between 7.5% and 12%.
- You agree to wear the study devices (Ypsomed pump with CamAPS HX algorithm) and Freestyle Libre 3 sensor, and follow the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special type of insulin delivery system (closed-loop) can help people with type 2 diabetes and chronic kidney disease. You'll wear a continuous glucose monitor and insulin pump, and researchers will track how your kidneys respond over time.
This study tests whether a treatment can help your pancreas make more insulin and possibly put your type 2 diabetes into remission. It is for people diagnosed with type 2 diabetes in the last 5 years who are already on diabetes medication.
This trial tests a smart insulin pump system (hybrid closed-loop) to control blood sugar in people with type 2 diabetes who need surgery and will receive nutrition through a vein. It aims to prevent high and low blood sugar during and after surgery.
This trial tests a 'closed-loop' system that automatically adjusts insulin delivery for people with type 2 diabetes. If you already use insulin and certain diabetes medications, this study could help see if a smart insulin pump improves blood sugar control.
This study tests a new automated insulin pump system (Omnipod) that adjusts insulin doses on its own throughout the day for people with type 2 diabetes. The goal is to see if it helps keep blood sugar levels more stable while reducing the burden of manual insulin management.
This study compares two advanced treatments for type 1 diabetes that is hard to control: a closed-loop insulin pump system (which automatically adjusts insulin) versus islet cell transplantation (which replaces the cells that make insulin). It is for people whose blood sugar stays very unstable despite using the best current therapies.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.